NNOX
Nano-X Imaging Ltd.
NASDAQ · Healthcare · Medical - Devices · IL
$0.75
−4.60%Year over year
Reported trailing growth
- Revenue
- +31.5%
- EBITDA
- —
- EBIT
- -77.5%
- EPS
- -88.9%
- Free cash flow
- -27.9%
- Operating cash flow
- -24.8%
Forward estimates
Based on analyst estimates
- Revenue
- +90.7%
- EBITDA
- +69.6%
- EPS
- +66.9%
Three-year CAGR
- Revenue
- +14.9%
- EBITDA
- -8.9%
- EBIT
- -7.0%
- Net income
- -40.2%
- EPS
- -27.5%
- Free cash flow
- -14.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026